Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Omer Akyurek
Visfatin May Be a Novel Marker for Identifying Stages of Essential Hypertension in Advanced Age Patients
Internal Medicine
Internal Medicine
Medicine
Clinical Outcome and Factors Affecting Surgical Decision for Repair Versus Replacement in Patients With Mitral Regurgitation
Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
Related publications
Serum Visfatin as a Novel Marker of Endothelial Dysfunction in Patients With Type 2 Diabetes
International Journal of Contemporary Medical Research [IJCMR]
Statins May Be Beneficial for Patients With Pulmonary Hypertension Secondary to Lung Diseases
Journal of Thoracic Disease
Pulmonary
Respiratory Medicine
Microalbuminuria, an Integrated Marker of Cardiovascular Risk in Essential Hypertension
Journal of Human Hypertension
Internal Medicine
Routine Measurement of Fibrinogen Concentration. Fibrinogen May Be Just a Marker.
BMJ
Increased Mean Platelet Volume in Patients With Familial Mediterranean Fever May Not Be a Marker of Atherosclerosis Risk
Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
Pretransplant Serum Ferritin Level May Be a Predictive Marker for Outcomes in Patients Having Undergone Allogeneic Hematopoietic Stem Cell Transplantation
Neoplasma
Cancer Research
Plasma Pentraxin 3 May Be a Better Marker of Peripheral Artery Disease in Hemodialysis Patients Than C-Reactive Protein
Vascular Medicine
Medicine
Cardiovascular Medicine
Cardiology
Serum TFF3 May Be a Pharamcodynamic Marker of Responses to Chemotherapy in Gastrointestinal Cancers
BMC Clinical Pathology
Forensic Medicine
Pathology
Histology
Ketanserin, a Novel 5-Hydroxytryptamine Antagonist: Monotherapy in Essential Hypertension.
British Journal of Clinical Pharmacology
Pharmacology
